Cargando…
Retraction notice to “Case-control study about the acceptance of Pegvaliase in Phenylketonuria” Molecular Genetics and Metabolism Reports 22 (2020) 100557.
Autor principal: | Krämer, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178674/ https://www.ncbi.nlm.nih.gov/pubmed/34168960 http://dx.doi.org/10.1016/j.ymgmr.2021.100750 |
Ejemplares similares
-
Case-control study about the acceptance of Pegvaliase in Phenylketonuria
por: Krämer, Johannes
Publicado: (2020) -
Successful desensitization of Pegvaliase (Palynziq®) in a patient with phenylketonuria
por: Patrawala, Meera, et al.
Publicado: (2020) -
Evidence- and consensus-based recommendations for the use of
pegvaliase in adults with phenylketonuria
por: Longo, Nicola, et al.
Publicado: (2018) -
A Comprehensive Review of Pegvaliase, an Enzyme Substitution Therapy for the Treatment of Phenylketonuria
por: Hydery, Tasmina, et al.
Publicado: (2019) -
Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics()
por: Adams, Darius, et al.
Publicado: (2021)